178 related articles for article (PubMed ID: 38087779)
1. In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition.
Guo Q; Zhang J; Parikh K; Brinkley A; Lin S; Zakarian C; Pernet O; Shimizu S; Khamaikawin W; Hacke K; Kasahara N; An DS
Mol Ther; 2024 Feb; 32(2):384-394. PubMed ID: 38087779
[TBL] [Abstract][Full Text] [Related]
2. Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection.
Porter CC; DeGregori J
Blood; 2008 Dec; 112(12):4466-74. PubMed ID: 18587011
[TBL] [Abstract][Full Text] [Related]
3. Genetic modification of mouse bone marrow by lentiviral vector-mediated delivery of hypoxanthine-Guanine phosphoribosyltransferase short hairpin RNA confers chemoprotection against 6-thioguanine cytotoxicity.
Hacke K; Treger JA; Bogan BT; Schiestl RH; Kasahara N
Transplant Proc; 2013 Jun; 45(5):2040-4. PubMed ID: 23769104
[TBL] [Abstract][Full Text] [Related]
4. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.
Shimizu S; Hong P; Arumugam B; Pokomo L; Boyer J; Koizumi N; Kittipongdaja P; Chen A; Bristol G; Galic Z; Zack JA; Yang O; Chen IS; Lee B; An DS
Blood; 2010 Feb; 115(8):1534-44. PubMed ID: 20018916
[TBL] [Abstract][Full Text] [Related]
5. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of HPRT for selection of genetically modified human hematopoietic progenitor cells.
Choudhary R; Baturin D; Fosmire S; Freed B; Porter CC
PLoS One; 2013; 8(3):e59594. PubMed ID: 23555045
[TBL] [Abstract][Full Text] [Related]
7. Combined preconditioning and in vivo chemoselection with 6-thioguanine alone achieves highly efficient reconstitution of normal hematopoiesis with HPRT-deficient bone marrow.
Hacke K; Szakmary A; Cuddihy AR; Rozengurt N; Lemp NA; Aubrecht J; Lawson GW; Rao NP; Crooks GM; Schiestl RH; Kasahara N
Exp Hematol; 2012 Jan; 40(1):3-13.e3. PubMed ID: 22001673
[TBL] [Abstract][Full Text] [Related]
8. RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice.
Shimizu S; Ringpis GE; Marsden MD; Cortado RV; Wilhalme HM; Elashoff D; Zack JA; Chen IS; An DS
Mol Ther Nucleic Acids; 2015 Feb; 4(2):e227. PubMed ID: 25689223
[TBL] [Abstract][Full Text] [Related]
9. Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1.
Khamaikawin W; Shimizu S; Kamata M; Cortado R; Jung Y; Lam J; Wen J; Kim P; Xie Y; Kim S; Arokium H; Presson AP; Chen ISY; An DS
Mol Ther Methods Clin Dev; 2018 Jun; 9():23-32. PubMed ID: 29322065
[TBL] [Abstract][Full Text] [Related]
10. Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.
Wolstein O; Boyd M; Millington M; Impey H; Boyer J; Howe A; Delebecque F; Cornetta K; Rothe M; Baum C; Nicolson T; Koldej R; Zhang J; Keech N; Camba Colón J; Breton L; Bartlett J; An DS; Chen IS; Burke B; Symonds GP
Mol Ther Methods Clin Dev; 2014; 1():11. PubMed ID: 26015947
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal clonal tracking in humanized mice reveals sustained polyclonal repopulation of gene-modified human-HSPC despite vector integration bias.
Suryawanshi GW; Arokium H; Kim S; Khamaikawin W; Lin S; Shimizu S; Chupradit K; Lee Y; Xie Y; Guan X; Suryawanshi V; Presson AP; An DS; Chen ISY
Stem Cell Res Ther; 2021 Oct; 12(1):528. PubMed ID: 34620229
[TBL] [Abstract][Full Text] [Related]
12. Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.
Burke BP; Levin BR; Zhang J; Sahakyan A; Boyer J; Carroll MV; Colón JC; Keech N; Rezek V; Bristol G; Eggers E; Cortado R; Boyd MP; Impey H; Shimizu S; Lowe EL; Ringpis GE; Kim SG; Vatakis DN; Breton LR; Bartlett JS; Chen IS; Kitchen SG; An DS; Symonds GP
Mol Ther Nucleic Acids; 2015 Apr; 4():e236. PubMed ID: 25872029
[TBL] [Abstract][Full Text] [Related]
13. The clonal repopulation of HSPC gene modified with anti-HIV-1 RNAi is not affected by preexisting HIV-1 infection.
Suryawanshi GW; Khamaikawin W; Wen J; Shimizu S; Arokium H; Xie Y; Wang E; Kim S; Choi H; Zhang C; Yu H; Presson AP; Kim N; An DS; Chen ISY; Kim S
Sci Adv; 2020 Jul; 6(30):eaay9206. PubMed ID: 32766447
[TBL] [Abstract][Full Text] [Related]
14. Tissue specific toxicities of the anticancer drug 6-thioguanine is dependent on the Hprt status in transgenic mice.
Aubrecht J; Goad ME; Schiestl RH
J Pharmacol Exp Ther; 1997 Aug; 282(2):1102-8. PubMed ID: 9262380
[TBL] [Abstract][Full Text] [Related]
15. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
[TBL] [Abstract][Full Text] [Related]
16. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
[TBL] [Abstract][Full Text] [Related]
17. Stem cell-based therapies for HIV/AIDS.
Pernet O; Yadav SS; An DS
Adv Drug Deliv Rev; 2016 Aug; 103():187-201. PubMed ID: 27151309
[TBL] [Abstract][Full Text] [Related]
18. Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells.
Carrillo MA; Zhen A; Mu W; Rezek V; Martin H; Peterson CW; Kiem HP; Kitchen SG
Mol Ther; 2024 Apr; 32(4):1000-1015. PubMed ID: 38414243
[TBL] [Abstract][Full Text] [Related]
19. Guanine nucleotide exchange factor Vav1 regulates perivascular homing and bone marrow retention of hematopoietic stem and progenitor cells.
Sanchez-Aguilera A; Lee YJ; Lo Celso C; Ferraro F; Brumme K; Mondal S; Kim C; Dorrance A; Luo HR; Scadden DT; Williams DA
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9607-12. PubMed ID: 21606370
[TBL] [Abstract][Full Text] [Related]
20. Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short-term culture in the presence of an aryl hydrocarbon receptor antagonist.
Gu A; Torres-Coronado M; Tran CA; Vu H; Epps EW; Chung J; Gonzalez N; Blanchard S; DiGiusto DL
Hum Gene Ther Methods; 2014 Aug; 25(4):221-31. PubMed ID: 25003230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
